Trevi Therapeutics (TRVI) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.13
-0.12
-0.1
-0.09

Details

Expected EPS
-0.12298
Actual EPS
-0.09
Surprise EPS
0.03
Surprise Percent
+26.82%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.09 per share for Q2 2025.

0 Comments

Share your thoughts